Raz I. (PI), Elias D. (C), Avron A. (C), Tamir M. (C), Metzger M. (C) and Cohen I.R (PI)   . b-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277) : a randomised, double blind, phase II trial. Lancet, 2001: 358, 1749-53. 38.278; 2/155; 304;304

Wainstein J. (PI), Metzger M. (C), Boaz M. (C), Minouchin O. (C), Cohen Y. (C), Yaffe A. (C), Yerushalmi Y. (C), Raz I (C)., and Harman-Boehm I (PI). Insulin pump therapy vs. Multiple daily injections in obese Type 2 diabetic patients. Diabet Med 2005 Aug; 22(8):1037-46.  2.902; 53/122; 43;43

Metzger M. (PI), Castaneda J. (C), Reznik Y (PI)., Giorgino F. (C), Conget I. (C), Aronson R. (C), De Portu S. (C), Runzis S. (C), Lee S. W. (C), and Cohen O (PI). Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial. Diabetes Obes Metab. 2017 Oct;19(10):1490-4.

Tsur A. (PI), Metzger M. (C), and Dresner-Pollak R. (PI). Effect of different dress style on vitamin D level in healthy young Orthodox and ultra-Orthodox students in Israel. Osteoporos Int. 2011 Oct; 22(11): 2895-2898.  4.997; 19/105; 0:0

Metzger M. (PI), Lederhandler L. (C), Corcos A. (C). Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients with Type 1 Diabetes on Continuous Subcutaneous Subcutaneous Insulin Infusion Therapy. Diabetes Care, 2015 March; 38:e34-e35.